Still Looking for a Simple, Effective Prevention Measure for Neonatal Sepsis in High-Mortality Settings.

[1]  H. Tinto,et al.  Effect of Intrapartum Azithromycin vs Placebo on Neonatal Sepsis and Death: A Randomized Clinical Trial. , 2023, JAMA.

[2]  P. J. Hooper,et al.  Global progress toward the elimination of active trachoma: an analysis of 38 countries. , 2022, The Lancet. Global health.

[3]  S. Madhi,et al.  Postmortem investigations and identification of multiple causes of child deaths: An analysis of findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) network , 2021, PLoS medicine.

[4]  Myron Anthony Godinho,et al.  Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. , 2021, Lancet.

[5]  S. Taylor,et al.  The influence of early-life microbial exposures on long-term respiratory health. , 2021, Paediatric Respiratory Reviews.

[6]  U. d’Alessandro,et al.  Long-lasting effect of oral azithromycin taken by women during labour on infant nutrition: Follow-up cohort of a randomized clinical trial in western Gambia , 2018, PloS one.

[7]  S. West,et al.  Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa , 2018, The New England journal of medicine.

[8]  B. Munoz,et al.  Antibiotic Resistance in Young Children in Kilosa District, Tanzania 4 Years after Mass Distribution of Azithromycin for Trachoma Control. , 2017, The American journal of tropical medicine and hygiene.

[9]  J. Clemente,et al.  The microbiome in early life: implications for health outcomes , 2016, Nature Medicine.

[10]  U. d’Alessandro,et al.  Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  J. Alexander,et al.  Cardiovascular risks with azithromycin and other antibacterial drugs. , 2013, The New England journal of medicine.

[12]  S. Madhi,et al.  Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial , 2009, The Lancet.

[13]  W. Andrews,et al.  Maternal and transplacental pharmacokinetics of azithromycin. , 2003, American journal of obstetrics and gynecology.